<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Strict//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-strict.dtd"><html xml:lang="en" lang="en" xmlns="http://www.w3.org/1999/xhtml"><head><meta http-equiv="Content-Type" content="text/html; charset=utf-8" /><meta name="ROBOTS" content="NOARCHIVE" /><meta name="googlebot" content="nosnippet" /><meta name="Document-Type" content="" /><meta name="keywords" content="Impotence see Erectile dysfunction; Erectile dysfunction; Priapism" /><meta name="IX" content="Erectile dysfunction; Priapism" /><meta name="IXN" content="Impotence see Erectile dysfunction" /><title>7.4.5 Drugs for erectile dysfunction: British National Formulary</title><link type="text/css" rel="stylesheet" href="../../theme/theme.css" /><link type="text/css" rel="stylesheet" href="../../theme/print.css" media="print" /><link type="text/css" rel="stylesheet" href="59/style.css" /><link type="image/x-icon" rel="shortcut icon" href="favicon.ico" /><link rel="stylesheet" type="text/css" href="style/screen.css" media="screen" /><link rel="stylesheet" type="text/css" href="style/print.css" media="print" /><link rel="contents" type="text/html" href="index.htm" /><link rel="help" type="text/html" href="http://www.medicinescomplete.com/mc/help_page.htm" /><link rel="start" type="text/html" href="index.htm" title="British National Formulary" /><link rel="copyright" type="text/html" href="PHP0-publication-information.htm" title="Copyright information" /><link rel="bookmark" title="Skip Navigation" href="PHP5145-drugs-for-erectile-dysfunction.htm#pB" /><script type="text/javascript" src="https://ajax.googleapis.com/ajax/libs/jquery/1.7.0/jquery.min.js"></script><script type="text/javascript" src="../../scripts/jquery/jquery.tooltip.min.js"></script><script type="text/javascript" src="../../scripts/jquery/jquery.cookie.js"></script><script type="text/javascript" src="../../scripts/jquery/jquery.autosuggest.js"></script><script type="text/javascript" src="../../scripts/scripts.js"></script><style type="text/css">
  .contentsbox { position: fixed; z-index:1001;}
  .contentsbox_wrap {overflow:hidden;width:20px;height:130px; position:absolute;left:0;top:0;}
</style><!--[if lte IE 7]>
          <style type="text/css">
          .contentsbox {
          position: absolute;
          left: expression( ( 15 + ( ignoreMe2 = document.documentElement.scrollLeft ? document.documentElement.scrollLeft : document.body.scrollLeft ) ) + 'px' );
          top: expression( ( 250 + ( ignoreMe = document.documentElement.scrollTop ? document.documentElement.scrollTop : document.body.scrollTop) ) + 'px' );
          }
          .threecol_col3 {
          font-family: arial
          }
          .threecol_col3 a {
          font-family: verdana,helvetica,sans-serif
          }
          .threecol_col1 {
          font-family: arial
          }
          .threecol_col1 a {
          font-family: verdana,helvetica,sans-serif
          }
          div#pE {
          font-family: arial
          }
          div#pE a {
          font-family: verdana,helvetica,sans-serif
          }
          div#pK {
          font-family: arial
          }
          div#pK a {
          font-family: verdana,helvetica,sans-serif
          }
          </style>
          <![endif]--></head><body><?highlighter off?><div id="pU"><a id="pD" accesskey="s" rel="bookmark" href="PHP5145-drugs-for-erectile-dysfunction.htm#pB" title="Skip Navigation">Skip Navigation</a><img src="../../images/mylogo.png" alt="BNF.org Free Access" id="pI" /><ul id="pZ"><li><a href="http://www.medicinescomplete.com/mc/account.htm">You are signed in as a member of <b>BNF.org Free Access</b></a></li><li> | <a href="http://www.medicinescomplete.com/mc/login.htm">Sign in different user</a></li><li> | <a href="http://www.medicinescomplete.com/mc/logout.htm">Sign out</a></li></ul><a href="http://www.medicinescomplete.com/mc/" title="Go to the MedicinesComplete home page"><img src="../../images/mc.png" alt="MedicinesComplete" /></a><ul id="pM"><li><a href="http://www.medicinescomplete.com/mc/" class="selected" accesskey="1" title="Home: access key 1"><strong><span>Home</span></strong></a></li><li><a href="http://www.medicinescomplete.com/mc/marketing/current/"><strong><span>Welcome</span></strong></a></li><li><a href="http://www.medicinescomplete.com/mc/feedback.htm?pub=bnf&amp;uri=PHP5145-drugs-for-erectile-dysfunction.htm" accesskey="9" title="Feedback: access key 9"><strong><span>Feedback</span></strong></a></li><li><a href="http://www.medicinescomplete.com/mc/help.htm" accesskey="6" title="Help button: access key 6"><strong><span>Help</span></strong></a></li></ul></div><div id="pA"><div id="pY">British National Formulary</div><div id="pG">Printed from: Joint Formulary Committee.  <i>British National Formulary</i>. [online] London: BMJ Group and Pharmaceutical Press.. &lt; http://www.medicinescomplete.com/ &gt; [Accessed on 06 Oct 2012 (GMT)].</div><div id="pQ"><form id="searchForm" method="get" action="http://www.medicinescomplete.com/mc/bnf/current/search.htm"><fieldset><legend>Details</legend><label for="q">Search for</label><div id="qd"><div><input accesskey="4" type="text" id="q" name="q" /><input class="button" id="searchButton" type="submit" value="Search" name="searchButton" title="Search full text" /></div></div></fieldset></form><script type="text/javascript">$(document).ready(function(){$("#q").autoSuggest('http://www.medicinescomplete.com/mc/bnf/current/search/suggest.xml', {control: "#searchButton"});});</script></div></div><div id="pH"><div id="pN"><div id="pT"><span class="cA"><a href="http://www.medicinescomplete.com/mc/">Home</a></span> &gt; <a href="index.htm">BNF September 2012</a> &gt; <a href="PHP4758-obstetrics-gynaecology-and-urinary-tract-disorders.htm">7 Obstetrics, gynaecology, and urinary-tract disorders</a> &gt; <a href="PHP5031-drugs-for-genito-urinary-disorders.htm">7.4 Drugs for genito-urinary disorders</a></div><div id="pP"><div class="threecol_col1">◄ <a accesskey="[" href="PHP5143-sodium-chloride.htm" title="Previous: SODIUM CHLORIDE">Previous page</a></div><div class="threecol_col2"> </div><div class="threecol_col3"><a accesskey="]" href="PHP5147-alprostadil.htm" title="Next: Alprostadil">Next page</a> ►</div></div></div></div><div id="p1"><div id="sideBar"><h2>See Also</h2><ul><li><h3>British National Formulary (11)</h3></li><li><a href="PHP4509-male-sex-hormones-and-antagonists.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">6.4.2 Male sex hormones and antagonists</a><div class="breadcrumb"><p><strong>British National Formulary</strong> &gt; 6 Endocrine system &gt; 6.4 Sex hormones</p></div></li><li><a href="PHP5150-caverject.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Caverject®</a><div class="breadcrumb"><p><strong>British National Formulary</strong> &gt; 7 Obstetrics, gynaecology, and urinary-tract disorders &gt; 7.4 Drugs for genito-urinary disorders &gt; 7.4.5 Drugs for erectile dysfunction &gt; Alprostadil &gt; ALPROSTADIL &gt; Intracavernosal injection</p></div></li><li><a href="PHP5151-viridal-duo.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Viridal® Duo</a><div class="breadcrumb"><p><strong>British National Formulary</strong> &gt; 7 Obstetrics, gynaecology, and urinary-tract disorders &gt; 7.4 Drugs for genito-urinary disorders &gt; 7.4.5 Drugs for erectile dysfunction &gt; Alprostadil &gt; ALPROSTADIL &gt; Intracavernosal injection</p></div></li><li><a class="seeAll" href="http://www.medicinescomplete.com/mc/related.htm?q=%22impotence%22%22erectile+dysfunction%22%22priapism%22" onclick="pageTracker._trackEvent('Related-Topic','Related-See-All');">see all (11)</a></li></ul><ul><li><h3>Dietary Supplements (3)</h3></li><li><a href="http://www.medicinescomplete.com/mc/diet/2010/c06.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Arginine</a><div class="breadcrumb"><p><strong>Dietary Supplements</strong> &gt; Monographs &gt; A</p></div></li><li><a href="http://www.medicinescomplete.com/mc/diet/2010/c43.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Ginseng</a><div class="breadcrumb"><p><strong>Dietary Supplements</strong> &gt; Monographs &gt; G</p></div></li><li><a href="http://www.medicinescomplete.com/mc/diet/2010/c81.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Pycnogenol</a><div class="breadcrumb"><p><strong>Dietary Supplements</strong> &gt; Monographs &gt; P</p></div></li></ul><ul><li><h3>Martindale: The Complete Drug Reference (2)</h3></li><li><a href="http://www.medicinescomplete.com/mc/martindale/2009/2079-q.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Metaraminol Tartrate</a><div class="breadcrumb"><p><strong>Martindale: The Complete Drug Reference</strong> &gt; Drugs and Ancillary Substances &gt; By therapeutic use &gt; Cardiovascular Drugs &gt; Drug Monographs</p></div></li><li><a href="http://www.medicinescomplete.com/mc/martindale/2009/330-a1-5-n.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Erectile dysfunction</a><div class="breadcrumb"><p><strong>Martindale: The Complete Drug Reference</strong> &gt; Drugs and Ancillary Substances &gt; By therapeutic use &gt; Urological Drugs &gt; Introduction</p></div></li></ul><ul><li><h3>Remington: The Science and Practice of Pharmacy</h3></li><li><a href="http://www.medicinescomplete.com/mc/rem/2012/c74-sec1-0023.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Vacuum constriction devices</a><div class="breadcrumb"><p><strong>Remington: The Science and Practice of Pharmacy</strong> &gt; Part 2: The Practice of Pharmacy &gt; Section 7: Fundamentals of Pharmacy Practice &gt; 74 Health Accessories</p></div></li></ul><script type="text/javascript" src="scripts/sidebar.js"></script></div><div id="pB"><h1><span>7.4.5 </span>Drugs for erectile dysfunction</h1><?highlighter on?><div id="pC" class="jN"><p>Reasons for failure to produce a satisfactory erection include <em>psychogenic</em>, <em>vascular</em>, <em>neurogenic</em>, and <em>endocrine abnormalities</em>; impotence can also be drug-induced. Intracavernosal injection or urethral application of vasoactive drugs under careful medical supervision is used for both diagnostic and therapeutic purposes.</p> <p>Erectile disorders may also be treated with drugs given by mouth which increase the blood flow to the penis. Drugs should be used with caution if the penis is deformed (e.g. in angulation, cavernosal fibrosis, and Peyronie's disease).</p> <div id="PHP5146"><h2>Priapism</h2><p>If priapism occurs with alprostadil, treatment should not be delayed more than 6 hours and is as follows: </p><p>Initial therapy by penile aspiration—using aseptic technique a 19–21 gauge butterfly needle inserted into the corpus cavernosum and 20–50 mL of blood aspirated; if necessary the procedure may be repeated on the opposite side. </p><p>If initial aspiration is unsuccessful a second 19–21 gauge butterfly needle can be inserted into the opposite corpus cavernosum and sterile physiological saline introduced through the first needle and drained through the second.</p><p>If aspiration and lavage of corpora are unsuccessful, <em>cautious</em> intracavernosal injection of a sympathomimetic (<a title="section: Sympathomimetics" href="PHP1409-sympathomimetics.htm">section 2.7.2</a>) with action on alpha-adrenergic receptors, continuously monitoring blood pressure and pulse (<em>extreme caution:</em> coronary heart disease, hypertension, cerebral ischaemia or if taking antidepressant) as follows:</p><ul><li><p>intracavernosal injections of phenylephrine 100–200 micrograms (0.5–1 mL of a 200 microgram/mL solution) every 5–10 minutes; max. total dose 1 mg [unlicensed indication] [<em>important:</em> if suitable strength of phenylephrine injection not available may be specially prepared by diluting 0.1 mL of the phenylephrine 1% (10 mg/mL) injection (<a title="preparation: Phenylephrine" href="PHP1433-phenylephrine.htm#PHP1433-phenylephrine">section 2.7.2</a>) to 5 mL with sodium chloride 0.9%]; </p> <p><em>alternatively</em></p> </li><li><p>intracavernosal injections of adrenaline 10–20 micrograms (0.5–1 mL of a 20 microgram/mL solution) every 5–10 minutes; max. total dose 100 micrograms [unlicensed indication] [<em>important:</em> if suitable strength of adrenaline not available may be specially prepared by diluting 0.1 mL of the adrenaline 1 in 1000 (1 mg/mL, <a title="preparation: Adrenaline/Epinephrine 1 in 1000" href="PHP1978-adrenalineepinephrine-1-in-1000-non-proprietary.htm#PHP1978-adrenalineepinephrine-1-in-1000-non-proprietary">section 3.4.3</a>) injection to 5 mL with sodium chloride 0.9%]; </p> <p><em>alternatively</em></p> </li><li><p>intracavernosal injection of metaraminol (<em>caution: has been associated with fatal hypertensive crises</em>); metaraminol 1 mg (0.1 mL of 10 mg/mL metaraminol injection, <a title="preparation: Metaraminol" href="PHP1425-metaraminol-non-proprietary.htm#PHP1425-metaraminol-non-proprietary">section 2.7.2</a>) is diluted to 50 mL with sodium chloride injection 0.9% and given carefully by slow injection into the corpora in 5-mL injections every 15 minutes [unlicensed indication].</p> </li></ul><p>If necessary the sympathomimetic injections can be followed by further aspiration of blood through the same butterfly needle.</p><p>If sympathomimetics unsuccessful, urgent surgical referral for management (possibly including shunt procedure).</p></div> <div><h2>Prescribing on the NHS</h2><p>Drug treatments for erectile dysfunction may only be prescribed on the NHS under certain circumstances (see individual preparations). The Department of Health (England) has recommended that treatment should also be available from specialist services (commissioned by Health Authorities and Primary Care Trusts, and operating under local agreement) when the condition is causing severe distress; specialist centres should use form FP10(HP) or form HBP in Scotland or form WP10HP in Wales and endorse them ‘SLS’ if the treatment is to be dispensed in the community. The following criteria should be considered when assessing distress:</p></div> <ul><li><p>significant disruption to normal social and occupational activities;</p> </li><li><p>a marked effect on mood, behaviour, social and environmental awareness;</p> </li><li><p>a marked effect on interpersonal relationships.</p> </li></ul> </div><div id="pS"><p>Sub-sections</p><ul class="jT"><li id="_PHP5147-alprostadil"><a href="PHP5147-alprostadil.htm" title="Alprostadil">Alprostadil</a></li><li id="_PHP5154-phosphodiesterase-type-5-inhibitors"><a href="PHP5154-phosphodiesterase-type-5-inhibitors.htm" title="Phosphodiesterase type-5 inhibitors">Phosphodiesterase type-5 inhibitors</a></li><li><a href="PHP5171-papaverine-and-phentolamine.htm" title="Papaverine and phentolamine">Papaverine and phentolamine</a></li></ul></div><?highlighter off?><div id="pE">◄ <a accesskey="[" href="PHP5143-sodium-chloride.htm">Previous: SODIUM CHLORIDE</a> | <a class="top" href="PHP5145-drugs-for-erectile-dysfunction.htm#">Top</a> | <a accesskey="]" href="PHP5147-alprostadil.htm">Next: Alprostadil</a> ►</div></div></div><div id="pF"><div id="pL"><div id="footer"><div id="footerinner"><ul><li><a accesskey="0" href="accessibility.htm" title="Accessibility information: access key 0">Accessibility</a> | </li><li><a href="http://www.medicinescomplete.com/mc/marketing/current/contact.htm">Contact Us</a> | </li><li><a href="privacy.htm" title="Cookie and Privacy Policy">Cookie and Privacy Policy</a> | </li><li><a accesskey="3" href="http://www.medicinescomplete.com/mc/sitemap.htm" title="Site Map: access key 3">Site Map</a> | </li><li><a accesskey="8" href="terms.htm" title="Terms and Conditions: access key 8">Terms and Conditions</a></li></ul></div></div></div><div id="pX"><p><a href="PHP0-publication-information.htm" rel="copyright">Copyright © BMJ Group and Pharmaceutical Press 2012. All rights reserved. </a></p></div></div><script type="text/javascript">$(document).ready(function(){$.ga('UA-9959526-1');});</script></body></html>